SU
Sartorius AG
SUVPF · OTC
$275.96 +0.00% (+$0.00)
1M +7.16%
Market Cap 16.9B €
P/E Ratio 86.29x
Div. Yield 0.31%
ROE 7.18%
Bulios Fair Price
$252.09
8.6% downside
Current Price
$275.96
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SUVPF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
8/9Valuation
20 /100
Expensive EV/EBITDA 19.81x
P/S 4.72x
P/B 6.00x
Growth
15 /100
Declining Rev. growth 5.38%
FCF growth 0.38%
Book val. growth 10.79%
Profitability
65 /100
Moderate Net margin 5.48%
Op. margin 17.68%
FCF margin 8.17%
Quality
28 /100
Poor ROE 7.18%
ROA 2.04%
Asset turnover 0.37x
Debt
36 /100
Moderate Current ratio 1.14x
Int. coverage 2.68x
Net debt/EBITDA 3.60x
Stability
49 /100
Moderate Rev. volatility 12.24%
EPS volatility 86.16%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SUVPF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael Grosse
Employees
14,042
Headquarters
Göttingen
Upcoming events
22 OCT
Earnings
Upcoming earnings report